Related references
Note: Only part of the references are listed.High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non- small- cell lung cancer
E. Pailler et al.
ANNALS OF ONCOLOGY (2015)
FGFR as potential target in the treatment of squamous non small cell lung cancer
Marcello Tiseo et al.
CANCER TREATMENT REVIEWS (2015)
Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
Shiyang Wu et al.
PLOS ONE (2015)
Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer
Angela Alama et al.
DRUG DISCOVERY TODAY (2014)
Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment
Antonio Marchetti et al.
PLOS ONE (2014)
A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells
Hung-Chih Lin et al.
CLINICA CHIMICA ACTA (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma
M. Ilie et al.
ANNALS OF ONCOLOGY (2012)
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Tobias M. Gorges et al.
BMC CANCER (2012)
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
Jian-Mei Hou et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer
Hans-Ulrich Schildhaus et al.
MODERN PATHOLOGY (2012)
FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms
Darren C. Tomlinson et al.
PLOS ONE (2012)
Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck
Priya Balasubramanian et al.
PLOS ONE (2012)
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Sabine Kasimir-Bauer et al.
BREAST CANCER RESEARCH (2012)
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
Jian-Mei Hou et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
Cristina Raimondi et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
A. Lecharpentier et al.
BRITISH JOURNAL OF CANCER (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Amit Dutt et al.
PLOS ONE (2011)
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
Jonathan Weiss et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer
Fumihiro Tanaka et al.
CLINICAL CANCER RESEARCH (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells
Lindsay Marek et al.
MOLECULAR PHARMACOLOGY (2009)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
